Skip to main content
. Author manuscript; available in PMC: 2022 Apr 1.
Published in final edited form as: Alzheimers Dement. 2021 Mar 1;17(4):584–594. doi: 10.1002/alz.12219

Table 3.

Demographic characteristics, mean performance, and frequency of low test performance across CU and MCI biomarker subgroups.

CU A−T−
(n = 146)
MCI A+T+
(n = 15)
p- value for
CU A−T− and
MCI A+T+
MCI A−T−
(n = 14)
p- value for
MCI A−T− and
MCI A+T+
Age Mean (SD) 66.32 (12.06) 82.58 (4.28) <0.001a 72.50 (12.55) 0.007a
Education Mean (SD) 15.24 (2.44) 14.33 (2.50) 0.173a 13.36 (2.37) 0.291a
Sex (% Male) 78 (53.4%) 9 (60.0%) 0.627b 8 (57.1%) 0.876b
Short Test of Mental Status c 36.18 (1.99) 32.00 (2.36) <0.001a 32.14 (3.21) 0.892a
CBB Lrn/WM Composite Mean (z) 0.21 (0.78) −1.49 (0.99) <0.001a −0.19 (0.75) <0.001a
CBB Lrn/WM Composite <0.001b 0.001b
 Normal z > −1 138 (95.2%) 4 (26.7%) 12 (85.7%)
 z ≤ −1 7 (4.8%) 11 (73.3%) 2 (14.3%)
CBB Attn/Psychomotor Mean (z score) −0.71 (1.13) −1.26 (1.14) 0.077a −1.54 (1.35) 0.548a
CBB Attn/Psychomotor Composite 0.082b 0.588b
 Normal z > −1 92 (63.0%) 6 (40.0%) 7 (50%)
 z ≤ −1 54 (37.0%) 9 (60.0%) 7 (50%)
a

p-values represent linear model ANOVAs for mean comparisons.

b

p-values represent Pearson’s Chi-squared test for frequency comparisons.

c

Performance is considered as part of consensus diagnosis.

Note. CU = cognitively unimpaired; A = amyloid; T = tau; MCI = mild cognitive impairment; CBB = Cogstate Brief Battery; Lrn/WM = Learning / Working Memory; Attn = Attention.